Nanomedicine
Scope & Guideline
Unlocking New Frontiers in Biomedical Engineering
Introduction
Aims and Scopes
- Nanoparticle-based drug delivery systems:
Research on various nanoparticle formulations designed for targeted and controlled drug delivery, enhancing therapeutic efficacy while minimizing side effects. - Theranostics:
Integration of therapeutic and diagnostic capabilities in nanomedicine, allowing for real-time monitoring of treatment responses and disease progression. - Nanotechnology in cancer treatment:
Exploration of nanomaterials that can be used for cancer therapy, including drug delivery, photothermal therapy, and immunotherapy. - Biocompatibility and toxicity studies:
Investigation of the biocompatibility and potential toxic effects of nanomaterials on biological systems, crucial for their clinical application. - Innovative formulations and synthesis methods:
Development of novel nanoparticles and nanocarriers, including lipid-based, polymeric, and metal nanoparticles, to improve drug solubility and stability. - Nanomedicine for infectious diseases:
Utilization of nanotechnology to enhance the efficacy of treatments against bacterial, viral, and fungal infections, including the development of vaccines. - Nanotechnology in regenerative medicine:
Application of nanomaterials in tissue engineering and regenerative therapies, focusing on enhancing healing and regeneration processes.
Trending and Emerging
- Personalized nanomedicine:
An increasing number of studies are focusing on tailoring nanomedicine approaches to individual patient profiles, enhancing treatment efficacy and safety. - Smart and stimuli-responsive nanocarriers:
Research on nanocarriers that respond to specific stimuli (e.g., pH, temperature, or light) to release drugs at targeted sites is gaining momentum, showcasing advanced delivery systems. - Nanomedicine for chronic diseases:
Emerging research is focusing on the application of nanotechnology in managing chronic diseases such as diabetes and cardiovascular conditions, reflecting a shift towards long-term health management. - Combination therapies using nanotechnology:
There is a growing trend in combining nanomedicine with other therapeutic modalities, such as immunotherapy and gene therapy, to enhance overall treatment outcomes. - Nanotechnology in vaccine development:
The COVID-19 pandemic has accelerated interest in nanotechnology's role in vaccine development, leading to innovative delivery systems and adjuvants. - Artificial intelligence in nanomedicine:
Integration of AI and machine learning in the design, synthesis, and application of nanomedicines is emerging as a significant theme, indicating a technological evolution in the field.
Declining or Waning
- Traditional small molecule therapies:
There is a noticeable decrease in studies focusing on conventional small molecule drugs as researchers shift towards more innovative nanomedicine approaches. - Basic mechanistic studies of nanoparticles:
Research that solely focuses on the fundamental mechanisms of nanoparticle interactions without clinical relevance is becoming less prevalent, as the field moves towards translational research. - In vivo studies in animal models:
Although still important, there is a growing preference for human-relevant models and clinical trials, leading to fewer publications centered on animal studies. - Nanoparticle applications in non-biomedical fields:
The focus on nanotechnology applications outside of direct medical contexts, such as environmental or industrial applications, is diminishing within the journal's scope.
Similar Journals
Nanomedicine Journal
Bridging Science and Medicine at the Nanoscale.Nanomedicine Journal, published by Mashhad University of Medical Sciences, serves as a vital platform for research and developments in the dynamic field of nanotechnology applied to medicine. With an ISSN of 2322-3049 and an E-ISSN of 2322-5904, this Open Access journal, operational since 2013, makes cutting-edge research freely accessible to encourage collaborative efforts in this rapidly evolving domain. The journal navigates various areas, including bioengineering, biomedical engineering, materials science, and pharmacology, holding prestigious rankings in categories relevant to these fields. The 2023 Scopus Rankings reveal its significant standing within the scientific community, particularly with a 76th percentile in general medicine. By bridging the gap between laboratory technologies and clinical applications, the Nanomedicine Journal aims to empower researchers, professionals, and students alike to contribute to the innovative landscape of nanomedicine. With a convergence period extending from 2019 to 2024 and an established reputation, this journal is essential for those pursuing advancements in therapeutic solutions and diagnostics through nanotechnology.
Nano LIFE
Innovating solutions through nanoscale research.Nano LIFE, published by World Scientific Publishing Company, is a multidisciplinary journal that delves into the dynamic fields of bioengineering, biomedical engineering, and pharmaceutical science, providing a platform for researchers to disseminate their cutting-edge findings. With an ISSN of 1793-9844 and e-ISSN 1793-9852, this journal emphasizes the significance of nanoscale research in healthcare and technology, positioning itself as a vital resource for professionals and academics alike. Although currently categorized in the Q4 quartile for multiple scientific disciplines in 2023, its unique focus on the intersection of nanotechnology and life sciences aims to elevate the discourse in these rapidly evolving sectors. Researchers can anticipate publishing innovative methodologies and results, contributing to the overall understanding and application of nanotechnology in medicine. Located in Singapore, Nano LIFE not only serves the global research community but also reflects the growing interest in nanotechnology across diverse fields.
Nanotechnology Science and Applications
Advancing the Frontiers of Nanotechnology.Nanotechnology Science and Applications, published by DOVE MEDICAL PRESS LTD, is a premier open-access journal dedicated to advancing knowledge in the fields of nanoscience and nanotechnology, particularly focusing on their applications in bioengineering, biomedical engineering, and pharmaceutical sciences. Since its inception in 2008, this journal has provided a platform for the dissemination of high-quality research that is rigorously peer-reviewed, ensuring that only the most impactful findings reach a global audience. With an impressive impact factor reflected in its recent categorization in the Q1 tier for Pharmaceutical Science and Q2 for Bioengineering and Nanoscience, it stands as a critical resource for researchers, practitioners, and students eager to explore the cutting-edge innovations within these rapidly evolving disciplines. The journal's commitment to accessibility and its robust indexing in Scopus—ranked highly in its respective categories—reinforces its importance as a leading forum for the exchange of scientific knowledge and the fostering of collaborative research in nanotechnology applications.
ACS Nano
Pioneering Research for a Nanotech FutureACS Nano, published by the American Chemical Society, stands as a prestigious journal in the domains of Engineering, Materials Science, Nanoscience, and Physics. With an exceptional impact factor reflecting its standing as a Q1 category journal in multiple disciplines, it plays a pivotal role in disseminating groundbreaking research from 2007 to 2024. Known for its rigorous peer-review process, the journal boasts impressive Scopus rankings—positioned at #1 in General Engineering and #6 in General Physics and Astronomy—placing it among the top 1% of journals in its field. Although it is not an open-access publication, ACS Nano provides a wealth of knowledge that is essential for advancing the development of nanotechnology and its applications across various industries. Researchers, professionals, and students alike will find in its pages a trove of innovative studies and insights that drive the future of materials science and engineering.
BIOMEDICAL MICRODEVICES
Unleashing Potential in Biomedical MicrodevicesBIOMEDICAL MICRODEVICES is a leading journal published by Springer that focuses on the innovative field of microdevices within biomedical engineering. With an ISSN of 1387-2176 and an E-ISSN of 1572-8781, BIOMEDICAL MICRODEVICES offers a prestigious platform for researchers to disseminate their findings from 1998 to 2024, demonstrating a long-standing commitment to advancing knowledge in this critical area. The journal is recognized for its significant contributions, boasting a Q2 ranking in Biomedical Engineering and Nanoscience and Nanotechnology, and a Q3 rank in Molecular Biology. Renowned for its rigorous peer-review process, it is positioned within the top 30% of its field according to Scopus rankings, making it a valuable resource for researchers and practitioners alike. Though it operates under a subscription model, the emphasis on quality and relevance within its scope ensures that BIOMEDICAL MICRODEVICES remains a vital source of cutting-edge research that bridges engineering and biological systems, fostering innovation and collaboration in the pursuit of novel health solutions.
BIOMATERIALS
Exploring the Frontiers of Biomaterials ScienceBIOMATERIALS, published by Elsevier Science Ltd, is a premier academic journal dedicated to the interdisciplinary field of biomaterials research. With an impressive impact factor, it ranks in the Q1 quartile across multiple categories including Bioengineering, Biomaterials, and Biophysics, showcasing its significance in advancing scientific knowledge. Established in 1980 and set to converge its discussions through 2025, this journal provides a critical platform for researchers and professionals to disseminate their findings on the development, application, and performance of biomaterials. The journal covers a wide range of topics, from the mechanics of materials to nanotechnology, and is highly regarded with top Scopus rankings in essential categories, including an exceptional position within the 99th percentile for Biophysics. Although not an open access journal, BIOMATERIALS remains vital for students and established researchers alike, ensuring accessibility to groundbreaking research in the field. Engage with cutting-edge studies that pave the way for innovative applications in medicine, engineering, and beyond.
Nanomedicine-Nanotechnology Biology and Medicine
Transforming Biology and Medicine with Nanoscience BreakthroughsNanomedicine-Nanotechnology Biology and Medicine is a leading journal published by Elsevier, dedicated to the exploration of innovative applications of nanotechnology in the fields of biology and medicine. With an ISSN of 1549-9634 and an E-ISSN of 1549-9642, this esteemed journal provides a platform for high-quality research, comprehensively covering areas including bioengineering, biomedical engineering, pharmaceutical science, and nanoscience. Notably, it holds a significant position in various categories with a Q2 ranking in multiple disciplines and a prestigious Q1 ranking in Pharmaceutical Science, emphasizing its impact within the scientific community. By facilitating access to cutting-edge studies and advancements, Nanomedicine-Nanotechnology Biology and Medicine serves as an essential resource for researchers, professionals, and students alike, contributing significantly to the ongoing development of nanomedicine and its pivotal role in improving healthcare outcomes. The journal operates without open access; however, it remains committed to disseminating valuable knowledge to a global audience.
Biomaterials Advances
Innovating Tomorrow's Solutions in BiomaterialsBiomaterials Advances is a premier journal published by Elsevier, dedicated to the rapidly evolving field of biomaterials. Established in the United Kingdom, this open-access journal aims to disseminate high-quality, peer-reviewed research that explores innovative biomaterial designs and their applications in bioengineering and biomedical engineering. With an impressive 2023 impact factor reflected in its Q1 rankings across multiple categories—including Bioengineering, Biomaterials, and Biomedical Engineering—Biomaterials Advances stands out as a critical platform for scholars and practitioners faced with advancing technologies and methodologies in the realm of materials science. Covering a broad range of topics, from biocompatibility to tissue engineering, this journal provides an inclusive forum for researchers seeking to contribute to the field. Its Scopus rankings further affirm its position as a leading resource, with notable standings in Biomedical Engineering (Rank #13), Biomaterials (Rank #8), and Bioengineering (Rank #11), all within the top percentiles. Researchers and students alike are encouraged to contribute and engage with the latest findings and innovations in biomaterials through this valuable publication.
Biomaterials Research
Advancing biomaterials for a healthier tomorrow.Biomaterials Research, published by the American Association for the Advancement of Science, is a prominent open access journal established in 2014, dedicated to advancing the field of biomaterials. Based in the United Kingdom, this journal has swiftly become an essential platform for researchers and practitioners, offering groundbreaking insights in biomaterials, biomedical engineering, ceramics and composites, and miscellaneous medical fields. With its impressive Q1 ranking across multiple relevant categories in 2023 and its strong Scopus rankings, including a remarkable 90th percentile in the medicine category, Biomaterials Research showcases high-quality, peer-reviewed research designed to address both practical and theoretical challenges in biomaterials science. As an open access journal, it promotes wider dissemination and accessibility of research findings, crucial for fostering innovation and collaboration within the scientific community. Researchers, professionals, and students alike are encouraged to contribute, read, and engage with the latest developments in this dynamic field.
JOURNAL OF MATERIALS SCIENCE-MATERIALS IN MEDICINE
Unleashing the Potential of Materials in Medical ApplicationsJOURNAL OF MATERIALS SCIENCE-MATERIALS IN MEDICINE is a leading peer-reviewed journal published by Springer, dedicated to advancing the field of biomedical materials science. With an ISSN of 0957-4530 and E-ISSN 1573-4838, this Open Access journal has been committed to providing researchers and professionals with freely accessible, high-quality research since 2021. It features an extensive scope spanning bioengineering, biomaterials, biomedical engineering, and biophysics, reflecting its significant impact within these interdisciplinary domains. Recognized within the Q2 category of the 2023 rankings in multiple fields, the journal proudly positions itself as a crucial resource for innovative materials that contribute to advancements in medical applications. With impressive Scopus rankings, including 26th in Biophysics and 40th in Materials Science for Biomaterials, researchers, students, and industry professionals alike can rely on this publication for cutting-edge insights that drive the future of medical materials and technologies. Based in Dordrecht, Netherlands, the journal provides a vibrant platform for sharing groundbreaking discoveries and fostering collaborative research among a global audience.